Lupus Erythematosus, Systemic: all 1,222 studies
Page 2 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLERecruitingNCT07331467Phase 1
- A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)RecruitingNCT07331272Phase 1
- Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.RecruitingNCT07330245
- A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus NephritisRecruitingNCT07328581Phase 2
- A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus ErythematosusRecruitingNCT07323173Phase 1
- Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLERecruitingNCT07318259Phase 1
- CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune DiseasesRecruitingNCT07315087Phase 1
- ACE1831 in Adult Subjects With Relapsed/Refractory Systemic Lupus Erythematosus （SLE）Not yet recruitingNCT07314567Not applicable
- The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLENot yet recruitingNCT07306585Phase 1
- Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune DiseasesRecruitingNCT07301164Early Phase 1
- A Study of SHR-2173 in Participants With Systemic Lupus ErythematosusRecruitingNCT07299422Phase 2
- The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related ThrombocytopeniaNot yet recruitingNCT07298733
- A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)RecruitingNCT07276958Phase 1
- Allogeneic UCB-derived CAR-T for SLERecruitingNCT07274059Early Phase 1
- CD19/BCMA CAR-T for SLENot yet recruitingNCT07266337Early Phase 1
- Ferroptosis Role in the Pathophysiology of Systemic Lupus ErythematosusRecruitingNCT07260942Not applicable
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus ErythematosusRecruitingNCT07260877Phase 2
- miR-101-3p and Autotaxin in SLE PatientsNot yet recruitingNCT07252141
- Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune DeficienciesRecruitingNCT07251179
- Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease PatientsRecruitingNCT07249060
- Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesRecruitingNCT07246096Early Phase 1
- Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RARecruitingNCT07237659Phase 1
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune DiseasesRecruitingNCT07236801Phase 1
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07236762Phase 1
- Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLERecruitingNCT07233642Phase 1
- 2-HOBA in Systemic Lupus ErythematosusRecruitingNCT07225543Phase 2
- Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)Enrolling by invitationNCT07221565Phase 1/2
- Alnuctamab for Refractory SLE (LATTE Study)RecruitingNCT07219563Phase 1
- Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE PatientsRecruitingNCT07215754
- Clinical Study of Cizutamig in Systemic Lupus ErythematosusRecruitingNCT07215663Phase 1
- A Study of CD19 UCAR-T Cells in Subjects With Autoimmune DiseasesNot yet recruitingNCT07212322Not applicable
- European LUpuS Inception-Cohort Developing initiATivENot yet recruitingNCT07209540
- Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsRecruitingNCT07201558Phase 1
- A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular TreatmentRecruitingNCT07201129Phase 3
- A Study of CC312 for Relapsed/Refractory Autoimmune DiseasesRecruitingNCT07193810Early Phase 1
- The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLERecruitingNCT07185269Phase 1/2
- Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus PatientsNot yet recruitingNCT07183007Not applicable
- Creating Health Course Study for People With Rheumatological Conditions and Mood DisordersRecruitingNCT07180537Not applicable
- Safety and Efficacy Study of CC312 for Moderate to Severe SLERecruitingNCT07177911Phase 1
- LUpus Eritematoso Sistemico NETwork and RegistryNot yet recruitingNCT07175610
- A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 ImmunosuppressantsRecruitingNCT07175285
- An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune DiseasesRecruitingNCT07174843Early Phase 1
- Associating Gastric Infection With Autoimmune Flare Severity in an EgyptiansNot yet recruitingNCT07157202
- Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in EgyptNot yet recruitingNCT07144514
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- The Diagnostic Utility of T Immunoglobulin G and T Immunoglobulin M Biomarkers in Patients With Systemic Lupus Erythematosus Disease : Associations With Disease Activity and DamageNot yet recruitingNCT07136337Not applicable
- OMERACT SLE DelphiNot yet recruitingNCT07136090
- Cardiac Imaging in Systemic Disorders: the ORACLES RegistryNot yet recruitingNCT07134166
- The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus NephritisNot yet recruitingNCT07130448
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesRecruitingNCT07123519Phase 1
- Anti CD19/BCMA CAR Gene Therapy for Autoimmune DiseasesRecruitingNCT07121777Not applicable
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 1
- UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus NephritisRecruitingNCT07109986Phase 1
- Safety and Efficacy of ONT01 in LupusRecruitingNCT07107659Early Phase 1
- A Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesRecruitingNCT07104721Phase 1
- Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve TreatmentRecruitingNCT07102030
- Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesRecruitingNCT07087912Phase 4
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesRecruitingNCT07085676Phase 1
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseRecruitingNCT07085104Phase 1
- Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung DiseaseRecruitingNCT07077486Phase 4
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT07077304
- A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.Not yet recruitingNCT07069972
- Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world StudyRecruitingNCT07056621
- Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)RecruitingNCT07053800Phase 2
- CAR-T Cells Therapy for Patients With Autoimmune DiseasesRecruitingNCT07052565Not applicable
- Anifrolumab Pregnancy StudyRecruitingNCT07049653
- Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem CellsRecruitingNCT07041801Phase 1/2
- A Study of KITE-363 in Participants With Refractory Autoimmune DiseasesEnrolling by invitationNCT07038447Phase 1
- Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLERecruitingNCT07031713Phase 1
- A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)RecruitingNCT07011043Phase 1
- Study of YK012 in Moderate to Severe Systemic Lupus ErythematosusRecruitingNCT07010835Phase 1/2
- Long-Term Outcomes in SLE at Peking University People's HospitalRecruitingNCT07005479
- A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus ErythematosusNot yet recruitingNCT07001839Phase 1
- Medical Follow-up of New Cases of Polyarthritis in Children and Young AdultsRecruitingNCT07000916
- Anifrolumab Malignancy and Serious Infections StudyRecruitingNCT07000110
- Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis StressNot yet recruitingNCT06999109Not applicable
- Transcutaneous Vagus Nerve Stimulation in SLERecruitingNCT06987565Phase 2
- A Study of OL-108 in Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06980597Phase 1
- UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune DiseasesNot yet recruitingNCT06978738Phase 1
- A Clinical Study of YTS109 Cell in R/R Autoimmune DiseasesRecruitingNCT06978647Phase 1
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)RecruitingNCT06977724Phase 1
- Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus NephritisRecruitingNCT06975787Phase 1
- Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06970951Early Phase 1
- Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus ErythematosusNot yet recruitingNCT06965244Phase 3
- Deciphering the Genetic Architecture of Autoimmune DiseasesRecruitingNCT06948110
- Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus ErythematosusRecruitingNCT06946485Early Phase 1
- An Open-label Study of GB261 in Refractory Seropositive Systemic Lupus ErythematosusNot yet recruitingNCT06945068Phase 1
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune DiseasesRecruitingNCT06941129Phase 1
- Study of BCMA/CD70 CAR-T Therapy for Refractory cSLERecruitingNCT06934447Phase 1
- Research Accelerated by You Lupus RegistryRecruitingNCT06927219
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune DiseaseRecruitingNCT06925542Phase 1
- HLA Antibodies in Systemic Lupus ErythematosusRecruitingNCT06921239
- UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus ErythematosusRecruitingNCT06920433Early Phase 1
- Physical Activity in Patients With Systemic Lupus ErythematosusNot yet recruitingNCT06919250
- A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)RecruitingNCT06917742Phase 1
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.RecruitingNCT06916806Phase 1
- Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06902844Not applicable
- A Study of CAR-T Cells in Subjects With Systemic Lupus ErythematosusNot yet recruitingNCT06900764Not applicable
- A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLERecruitingNCT06897930Phase 1/2
- Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLERecruitingNCT06892145Phase 1